Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiroxostat in early stage diabetic nephropathy
NCT02327754Phase 2Completed
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topiroxostat in diabetic nephropathy (DN), sponsored by Sanwa Kagaku Kenkyusho Co., Ltd.. Status: completed.
02
Drugs
topiroxostat
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT02327754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02327754.